HIV and malnutrition: effects on immune system

S Duggal, TD Chugh, AK Duggal - Journal of Immunology …, 2012 - Wiley Online Library
HIV or human immunodeficiency virus infection has assumed worldwide proportions and
importance in just a span of 25 years. Continuous research is being done in many parts of …

The T-cell response to HIV

B Walker, A McMichael - Cold Spring …, 2012 - perspectivesinmedicine.cshlp.org
HIV is a disease in which the original clinical observations of severe opportunistic infections
gave the first clues regarding the underlying pathology, namely that HIV is essentially an …

Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection

JM Angelosanto, SD Blackburn, A Crawford… - Journal of …, 2012 - Am Soc Microbiol
ABSTRACT T cell exhaustion and loss of memory potential occur during many chronic viral
infections and cancer. We investigated when during chronic viral infection virus-specific CD8 …

Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection

TH Evering, S Mehandru, P Racz… - PLoS …, 2012 - journals.plos.org
Mucosal mononuclear (MMC) CCR5+ CD4+ T cells of the gastrointestinal (GI) tract are
selectively infected and depleted during acute HIV-1 infection. Despite early initiation of …

Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion

S Lodi, L Meyer, AD Kelleher, M Rosinska… - Archives of internal …, 2012 - jamanetwork.com
Background There is interest in whether a short course of combination antiretroviral therapy
(cART) at the time of human immunodeficiency virus (HIV) seroconversion could induce long …

HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy

C Goujard, I Girault, C Rouzioux, C Lécuroux… - Antiviral …, 2012 - journals.sagepub.com
Background The occurrence of viral control after interruption of an antiretroviral treatment
(ART) initiated during primary HIV-1 infection (PHI) is rare and the frequency and predictive …

The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1–infected individuals

CM Hogan, V DeGruttola, X Sun… - Journal of Infectious …, 2012 - academic.oup.com
Abstract (See the editorial commentary by Tossonian and Conway, on pages 10–12.)
Background. The benefits of antiretroviral therapy during early human immunodeficiency …

Detection of acute HIV infection: we can't close the window

BM Branson, JD Stekler - Journal of Infectious Diseases, 2012 - academic.oup.com
Acute human immunodeficiency virus (HIV) infection poses a dilemma for diagnosis, clinical
management, and public health. It has been variously defined as the transient symptomatic …

Developing strategies for HIV-1 eradication

CM Durand, JN Blankson, RF Siliciano - Trends in immunology, 2012 - cell.com
Highly active antiretroviral therapy (HAART) suppresses HIV-1 replication, transforming the
outlook for infected patients. However, reservoirs of replication-competent forms of the virus …

No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial

ML Grijsen, R Steingrover, FWNM Wit, S Jurriaans… - PLoS …, 2012 - journals.plos.org
Background The objective of this study was to assess the benefit of temporary combination
antiretroviral therapy (cART) during primary HIV infection (PHI). Methods and Findings Adult …